Latest Insider Transactions at Integra Lifesciences Holdings Corp (IART)
This section provides a real-time view of insider transactions for Integra Lifesciences Holdings Corp (IART). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTEGRA LIFESCIENCES HOLDINGS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTEGRA LIFESCIENCES HOLDINGS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2022
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
293
-1.51%
|
$16,115
$55.34 P/Share
|
|
Aug 02
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Open market or private sale
|
Direct |
437
-4.72%
|
$24,472
$56.77 P/Share
|
|
Aug 01
2022
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
599
-2.31%
|
$33,544
$56.87 P/Share
|
|
Aug 01
2022
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
456
-2.29%
|
$25,536
$56.87 P/Share
|
|
Jul 27
2022
|
Renee Wonlai Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,969
+50.0%
|
-
|
|
Jul 01
2022
|
Glenn Coleman Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,666
-16.15%
|
$366,630
$55.0 P/Share
|
|
Jul 01
2022
|
Carrie L Anderson Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,425
-7.11%
|
$243,375
$55.0 P/Share
|
|
Jun 15
2022
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
900
-4.32%
|
$49,500
$55.93 P/Share
|
|
May 24
2022
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
250
-1.19%
|
$14,750
$59.85 P/Share
|
|
May 14
2022
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
131
-0.23%
|
$7,729
$59.32 P/Share
|
|
May 13
2022
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
4,215
+0.37%
|
-
|
|
May 13
2022
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,721
+4.53%
|
-
|
|
May 13
2022
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,456
+6.61%
|
-
|
|
May 13
2022
|
Donald E Morel Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,456
+5.84%
|
-
|
|
May 13
2022
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,721
+2.8%
|
-
|
|
May 13
2022
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,721
+23.82%
|
-
|
|
May 13
2022
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,089
+3.47%
|
-
|
|
Apr 04
2022
|
Glenn Coleman Executive Vice President & COO |
SELL
Open market or private sale
|
Direct |
6,268
-13.18%
|
$413,688
$66.04 P/Share
|
|
Mar 23
2022
|
Tru St Partnership, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-1.73%
|
$9,600,000
$64.67 P/Share
|
|
Mar 13
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
502
-1.31%
|
$32,630
$65.11 P/Share
|
|
Mar 13
2022
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,197
-2.01%
|
$142,805
$65.11 P/Share
|
|
Mar 13
2022
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,869
-1.82%
|
$186,485
$65.11 P/Share
|
|
Mar 13
2022
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,437
-1.63%
|
$93,405
$65.11 P/Share
|
|
Mar 13
2022
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-1.56%
|
$163,995
$65.11 P/Share
|
|
Mar 13
2022
|
Glenn Coleman Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,439
-28.23%
|
$678,535
$65.11 P/Share
|
|
Mar 13
2022
|
Carrie L Anderson Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,103
-2.4%
|
$201,695
$65.11 P/Share
|
|
Mar 12
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
504
-1.66%
|
$32,760
$65.11 P/Share
|
|
Mar 12
2022
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,188
-2.46%
|
$142,220
$65.11 P/Share
|
|
Mar 12
2022
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,440
-1.16%
|
$93,600
$65.11 P/Share
|
|
Mar 12
2022
|
Lisa Evoli EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,215
-1.73%
|
$78,975
$65.11 P/Share
|
|
Mar 12
2022
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,051
-1.6%
|
$133,315
$65.11 P/Share
|
|
Mar 12
2022
|
Glenn Coleman Executive Vice President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,583
-3.5%
|
$427,895
$65.11 P/Share
|
|
Mar 12
2022
|
Carrie L Anderson Executive Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,878
-1.42%
|
$187,070
$65.11 P/Share
|
|
Mar 11
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,430
+12.22%
|
-
|
|
Mar 11
2022
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
11,012
+16.54%
|
-
|
|
Mar 11
2022
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
9,792
+19.02%
|
-
|
|
Mar 11
2022
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
9,655
+17.72%
|
-
|
|
Mar 11
2022
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
7,877
+8.69%
|
-
|
|
Mar 11
2022
|
Glenn Coleman Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,119
+9.93%
|
-
|
|
Mar 11
2022
|
Carrie L Anderson Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,755
+12.18%
|
-
|
|
Mar 02
2022
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-2.36%
|
$31,222
$67.59 P/Share
|
|
Mar 01
2022
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,712
-5.09%
|
$112,992
$66.32 P/Share
|
|
Feb 28
2022
|
Lisa Evoli EVP & CHRO |
SELL
Open market or private sale
|
Direct |
1,254
-8.19%
|
$84,018
$67.03 P/Share
|
|
Feb 11
2022
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
13,358
+12.62%
|
-
|
|
Feb 11
2022
|
Lisa Evoli EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
7,962
+17.74%
|
-
|
|
Feb 11
2022
|
Carrie L Anderson Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
16,035
+14.82%
|
-
|
|
Feb 11
2022
|
Glenn Coleman Executive Vice President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
29,305
+17.39%
|
-
|
|
Feb 11
2022
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
9,990
+16.76%
|
-
|
|
Feb 11
2022
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,836
+10.7%
|
-
|
|
Feb 11
2022
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
10,539
+10.52%
|
-
|